fbpx

The Q Factor: Unlocking the Power of Coenzyme Q10 and L-Carnitine

Coenzyme Q10 (CoQ10) and L-carnitine are vital nutrients that play crucial roles in energy production and cellular health. While often overlooked, these compounds have significant implications for heart health, athletic performance, and overall well-being.

What are Q10 and L-carnitine?

  • CoQ10: A powerful antioxidant found in every cell of the body, essential for energy production within the mitochondria.
  • L-Carnitine: An amino acid-like compound crucial for transporting fatty acids into the mitochondria for energy production.

Why are they important?


  • Energy Production: Both Q10 and L-carnitine are critical for cellular energy production, a process that declines with age.
  • Antioxidant Protection: Q10 acts as a potent antioxidant, protecting cells from damage caused by free radicals.
  • Heart Health: Both compounds play vital roles in maintaining heart health, with benefits observed in conditions like heart failure, angina, and arrhythmias.
  • Athletic Performance: Q10 and L-carnitine can enhance athletic performance by improving energy production, reducing muscle fatigue, and aiding recovery.
  • Immune Function: By supporting cellular energy and protecting against oxidative stress, Q10 and L-carnitine contribute to a healthy immune system.

Depletion of Q10 and L-carnitine:

  • Age-Related Decline: Production of both compounds declines with age, contributing to age-related health issues.
  • Lifestyle Factors: Factors like heavy alcohol consumption and liver disease can further deplete Q10 and L-carnitine levels.

Q10 and L-carnitine for Optimal Health:

  • Heart Health: Supplementation with Q10 and L-carnitine has shown promise in improving heart function in patients with heart failure and other cardiovascular conditions.
  • Athletic Performance: Athletes can benefit from supplementation to enhance endurance, improve recovery, and reduce muscle fatigue.
  • Anti-Aging: By supporting mitochondrial function and combating oxidative stress, Q10 and L-carnitine may play a role in slowing down the aging process.
  • Immune Support: These nutrients can help strengthen the immune system and protect against infections.
Amino-Mix

Important Considerations:

  • Quality of Supplementation: Choose high-quality supplements from reputable brands.
  • Dosage: Optimal dosages may vary depending on individual needs and health conditions.
  • Consult with a Healthcare Professional: It’s essential to consult with a healthcare professional before starting any new supplement regimen, especially if you have any underlying health conditions or are taking medications.  

Conclusion

Coenzyme Q10 (CoQ10) and L-carnitine are vital nutrients that play crucial roles in numerous physiological processes. By supporting cellular energy production, protecting against oxidative stress, and enhancing cardiovascular function, these compounds offer significant health benefits. While further research is needed, available evidence suggests that supplementation with Q10 and L-carnitine may be beneficial for individuals seeking to improve their overall health, enhance athletic performance, and support healthy ageing.

References
  1. Kamei M et al, Intl J Vit Nut Res 56:57 1986
  2. Hodges S et al, Biofactors 9:365-370, 1999
  3. Mitchell P, J Theoret Biol 62:327-367, 1976
  4. Littaru, GP, Energy & Defence, Facts and Perspectives on Coenzyme Q10 in Biology and Medicine, Casa Editrice Scientifica Internazionale Rome, 1994
  5. Buznakow E et al, Biomed & Clin Aspects of Q10, Eds. Folkers K e al, Vol 3, Elsevier, Amersterdam 1988; pp311-323
  6. Langsjoen H et al, Am J Cardiology 65:521-523, 1990
  7. Langsjoen PH et al, Proc Natl Acad Sci USA 82:4240-4244, 1985
  8. Morisco C et al, Clin Investig 71: S134-136 1993
  9. Lockwood K et al, Biomed and Biophys Res Comm, 199(3):1504-1508, 1994
  10. Nylander M et al, Proc 8th Intl Sympsm Q10, Stockholm 1993
  11. Hanioka T et al, Ibid
  12. Yamabe H et al, Biomed & Clin Aspects of CoQ10, Vol 6, Eds. Folkers K et al, Elsevier, Amsterdam 1991; pp535-540,
  13. Zeppilli P et al, Ibid, pp 541-546
  14. Fiorella P et al, Ibid, pp513-520
  15. Hansen IL et al, Res Commun Chem Path Pharm 14:4:729-738, 1976
  16. Nylander M, Biomed 4:6-11, 1991
  17. Shizukuishi S et al, Biomed & Clin Aspects of Q10: 5:359-368, 1986
  18. Wilkinson EG et al, Biomed & Clin Aspects of Q10: 1:251-266, 1977
  19. Wilkinson EG et al, Res Commun Chem Path Pharm 14:4:715-719, 1976
  20. Wilkinson EG et al, Res Commun Chem Path Pharm 12:1:111-123, 1975
  21. Stocker R, Antioxidants & Disease Prevention: Biochem, Nut & Pharmacol Aspects, ILSI Intl Symposium, Stockholm June/July 1993; pp45-46
  22. Ingold KU et al, Proc Natl Acad Sci USA 90:45-49, 1993
  23. Stocker R et al, Antioxidants, Vitamins & Beta Carotene in Disease Prevention, 2nd Intl Conf, Berlin 1994; Abs p17
  24. Ernster L et al, BioFactors 3:241-248, 1992
  25. Forsmark P et al, FEBS Letters 285:39-43, 1991
  26. Takayanagi R et al, Biochemical J 192:853-860, 1980
  27. Takeshige K, Minakami S, J Biochem 77:1067-1073, 1975
  28. Takeshige K et al, Biomed & Clin Aspects Of CoQ10, Vol 2, Eds.Folkers K, Yamamura , Elsevier, Amsterdam 1980; pp15-26
  29. Mellors A, Tappel AL, J Biol Chem 241:4353-4356, 1966
  30. Bäckström D et al, Biochim Biophys Acta 197:108-111, 1970
  31. King TE, CoQ: Biochem, Bioenergetics & Clin Actions ofUbiquinone, Ed. Lenaz G, Wiley, NY 1985; p391
  32. Kröger A, Klingenberg M, Eur J Biochem 34:358-368, 1973
  33. Mellors A, Tappel AL, Lipids 1:282-284, 1966
  34. Yuziriha T et al, Biochim Biophys Acta 759:286, 1983
  35. Karlsson J et al, Klinische Wochenschr 71:S84-91, 1993
  36. Mohr D et al, Biochim Biophys Acta 1126:247-254, 1992
  37. Tomono Y et al, Intl J Clin Pharmacol Tox 24:536-541, 1986
  38. Kishi H et al, Biochem & Clin Aspects of CoQ10, Vol 4, Eds. Folkers K et al, Elsevier, Amsterdam 1984; pp131-142
  39. Lucker PF et al, Ibid, pp143-151
  40. Greenberg SM et al, Med Clin N Am 72:243-258, 1988
  41. Folkers K et al, Proc Natl Acad Sci USA 82:4513-4516, 1985
  42. Beyer RE et al, Mech of Ageing & Dev 32:267-281, 1985
  43. Apelqvist EL et al, Biomed and Clinical Aspects of CoQ10, Vol 6,Eds. Folkers K et al, Elsevier, Amsterdam 1991; pp141-150
  44. Lenaz G et al, Ibid, pp11-18
  45. Valls V et al, Biomarkers of Ageing; Expression and Regulation,Eds. Licastro F & Calderra CM, CLUEB, Bologna 1992; pp389-396
  46. Kalen A et al, Lipids 24:579-584, 1989
  47. Beyer RE, Free Rad Biol Med 5:297-303, 1988
  48. Beyer RE et al, Biomed & Clin Aspects of CoQ 10, Vol 5, Eds. Folkers K , Yamamua Y, Elsevier, Amsterdam 1986; pp17-24
  49. Lenaz G et al, Klinische Wochenschr 71:S71-75, 1993
  50. Judy WV et al, Biomed and Clinical Aspects of CoQ10, Vol 5, Eds. Folkers K et al, Elsevier, Amsterdam, 1986; pp315-323
  51. Hofman-Bang C et al, J Am College Cardiol 19:216A, 1992
  52. Lampertico M, Comis S, Klinische Wochenschr 71:S129-133, 1993
  53. Morisco B et al, Clin Invest 71 (8 Suppl):S134-S136, 1993
  54. Permanetter B et al, Eur Heart J 13:1528-1533, 1992
  55. Wilson MF et al, Biomed and Clinical Aspects of CoQ10, Vol 6, Eds. Folkers K et al, Elsevier Amsterdam, 1991; pp339-348
  56. Baggio E et al, Klinische Wochenschr 71:S145-149, 1993
  57. Oda T, Ibid, S150-154
  58. Karlsson J et al, Biomed and Clinical Aspects of CoQ10, Vol 6, Eds. Folkers K et al, Elsevier Amsterdam, 1991
  59. Karlsson J et al, Eur Heart J 13:758-762, 1992
  60. Karlson J et al, Highlights in Ubiquinone Research, Eds. Lenaz G,Barnabei O, Rabbi A, Battino M, Taylor & Francis, London,1990
  61. Karlsson J et al, Ann Med 23:339-344, 1991
  62. Karlsson J, Advances in Myochemistry, Ed. Benzi G, Libbey, London, 1987
  63. Kiessling K-H et al, Coronary Artery Disease & Physical Fitness, Eds. Larsen OA, Malmborg RO, Munksgaard, Copenhagen 1970
  64. Kiessling K-H et al, Clin Science 44:547-554, 1973
  65. Ernster L et al, Eur J Biochem 9:299-310, 1969
  66. Folkers K et al, Intl J Vit Res 40:380-390, 1970
  67. Littaru GP et al, Proc Natl Acad Science 68:2332-2335, 1971
  68. Folkers K et al, J Molec Med 2:431-460, 1977
  69. Iwamoto Y et al, Biomed and Clinical Aspects of CoQ10, Vol 3, Eds. Folkers K et al, Elsevier, Amsterdam 1981; pp109-119
  70. Ernster L, Forsmark-Andrea P, Clin Investig 71:560-565, 1993
  71. Awata N et al, Biomed and Clinical Aspects of CoQ10, Vol 2, Eds. Folkers K et al, Elsevier, Amsterdam 1980; pp247-253
  72. Cacciapuoti F, Gentille S, Ibid Vol 6, 1991; pp481-488
  73. Kawajiri K, Fujii-Kuriyama Y, Jpn J Cancer Res 82:1325-1335, 1991
  74. Tawfiq N et al, Eur J Cancer Prev 3:285-292, 1994
  75. Jollier P et al, Intl J Clin Pharmacol Ther 36:506-509, 1998
  76. Ernster L, Stockholm Univ: personal communication
  77. Weber C et al, Molec Asp Med 15:S97-S102, 1995
  78. Folkers K et al, Molec Asp Med 15:S281-285, 1995
  79. Bargossi AM et al, Molec Asp Med 15:S187-193, 1995
  80. Shigenaga MK et al, Proc Natl Acad Science 91:23 (Nov 8 1994; pp10771-10778)
  81. Chello M et al, Ann Thoracic Surg 58(5):1427-1432, 1994
  82. Vina J et al, Antioxidants, Vitamins & Beta Carotene in Disease Prevention, 2nd Intl Conf, Berlin 1994; Abs p95
  83. Adembri C et al, Histology & Histopathology 9(4):683-690, 1994
  84. Gugger ET, Erdman JW, Antioxidants, Vitamins & Beta Carotene in Disease Prevention, 2nd Intl Conf, Berlin 1994; Abs p53
  85. Gonzales R et al, Cancer Research 44:4137-4139, 1984
  86. Baum RM, Chem Eng News 20-26, Apr 9 1984
  87. Ernster L, Dallner G, Biochim Biophys Acta 1271(1):195-204, 1995
  88. Alleva R et al, Proc Natl Acad Sci USA 92:9388-9391, 1995
  89. Lockwood K et al, Biochem Biophys Res Comm 212:172-177, 1995
  90. Folkers K et al, Biochem Biophys Res Comm 192:241-245, 1993
  91. Harman D, Age 18:51-62, 1995
  92. Laaksonen R et al, Eur J Applied Physiol & Occupational Physiol 72:95-100, 1995
  93. Stocker R, Biomed & Clin Aspects of Coenzyme Q, 9th Intl Symposium, Ancona, May 16-19, 1996; Abs pp16-17
  94. Bowry WV et al, J Biol Chem 270:5756-5763, 1995
  95. Alleva R et al, Biomed & Clin Aspects of Coenzyme Q, 9th Intl Symposium, Ancona, May 16-19, 1996; Abs pp18-19
  96. Mortensen SA et al, Ibid, Abs p25
  97. Langsjoen PH et al, Ibid, Abs p26
  98. Oda T, Ibid, Abs p27
  99. Soja AM, Mortensen SA, Ibid, Abs p29
  100. Tarui S et al, Ibid, Abs p35
  101. Ogasawara et al, Neurology 35:372, 1985
  102. Ogasawara et al, Neurology 36:45, 1986
  103. Suzuki Y et al, Biomed & Clin Aspects of Coenzyme Q, 9th Intl Symposium, Ancona, May 16-19, 1996; Abs p36
  104. Wakabayashi T et al, Ibid, Abs p9
  105. Sohal RS, Ibid, Abs p13
  106. Lönnrot K et al, Ibid, Abs p53
  107. Linane AW, Ibid, Abs pp45-46
  108. Alho H et al, Ibid, Abs p20
  109. Lewin A, Ibid, Abs p47
  110. Kalen A et al, Biochim Biophys Acta 926:70-78, 1987
  111. Lockwood K et al, Biomed Biophys Res Comm, 199(3):1504-1508,
  112. Lockwood K et al, Biochem Biophys Res Comm 212:172-177, 1995
  113. Folkers K et al, Biochem Biophys Res Comm 192:241-245, 1993
  114. Lockwood K et al, Biomed & Clin Aspects of Coenzyme Q10, 9th Intl Symposium, Ancona May 16-19, 1996; Abs p50
  115. Beyer RE et al, Ibid, Abs p3-4
  116. Crane FL, Navas P, Ibid, Abs p1
  117. Lenaz G, Ibid, Abs p5
  118. Nohl H, Ibid, Abs p6
  119. Navas P, Villalba JM, Ibid, Abs p2
  120. Kishi T et al, Ibid, Abs p12
  121. Fritz IB, Advances Lipid Research 1:285-334, 1963
  122. Greenhaff P, personal communication
  123. Casey AD et al, Am J Physiol 271:E31-E37, 1996
  124. Greenhaff PL et al, Am J Physiol 266:E725-E730, 1994
  125. Greenhaff PL et al, Clin Science 84:565-571, 1993
  126. Harris RC et al, Clin Science 83:367-374, 1992
  127. Green AL et al, Acta Physiol Scanda, 158:2 195-202, 1996
  128. Green Al et al, Am J Physiol 271:E821-E826, 1996
  129. Hogan MC et al, Med & Sci in Sports & Exercise 27:371-377, 1995
  130. McVeigh J, Lopaschuk GD, Am J Physiol 259:H1079-H1085, 1990
  131. Jos OD et al, Cardiovasc Research 10:427-436, 1976
  132. Higgins AJ et al, Biochem Biophys Res Comm 100:291-296, 1981
  133. Dyck DJ et al, Am J Physiol 265:E852-E859, 1993
  134. Putman CT et al, Am J Physiol 268:E1007-E1017, 1995
  135. Timmons JA et al, J Clin Investig 97:879-883, 1996
  136. Colombani P et al, Eur J Applied Physiol & Occupational Physiol 73:434-439, 1996
  137. Lukaski HC et al, Am J Clin Nut 63:954-965, 1996
  138. Malm C et al, Acta Physiol Scandinavica 157:511-512, 1996
  139. Heinomen OJ, Sports Med 22:109-132, 1996
  140. Hallmark MA et al, Med & Science in Sports & Exercise 28:139-144, 1996
  141. Singh RB et al, Cardiovasc Drugs & Therapy 12:347-353, 1998
  142. Scheinen A, Mäkinen KK, Acta Odont Scand 33:590, 1975
  143. Khambanorida S et al, J Bio Buccale 11:255, 1983
  144. Scheinen A et al, Oral Health 71:33, 1981
  145. Mäkinen KK, J Dent Res 74:1904-1923, 1995
  146. Mäkinen KK, personal communication
  147. Bliznakov EG, Proc Natl Acad Science, 70:390-394 1973
  148. Bliznakov EG, Biomed Clin Aspects of Coenzyme Q10, 1:73-84, 1984
  149. Bliznakov EG, Macrophages and Lymphocytes, Pt A:361-369, 1980
  150. Folkers K et al, Biochem Biophys Res Comm 192:214-245, 1997
  151. Ihse I et al, Biomed & Clin Aspects of Coenzyme Q10, 8th Intl Symposium,1993; Abs p48
  152. Lockwood K et al, Biomed & Clin Aspects of Coenzyme Q10, 8th Intl Symposium,1993; Abs p49
  153. Lockwood K et al, Biomed Biophys Res Comm 212:172-177, 1995
  154. Lockwood K et al, Biomed & Clin Aspects of Coenzyme Q10, 9th Intl Symposium,1996; Abs p50
  155. Gugger ET, Erdman JW, Antioxidants, Vitamins & Beta Carotene in Disease Prevention, 2nd Intl Conf, Berlin 1994; Abs p53
  156. Kobayashi A et al, Japan Circ J 56:86-94, 1992
  157. Ghidini O et al, Intl J Clin Pharm Ther Tox 26:217-220, 1988
  158. Pepine C et al, The Carnitine System: A Novel Therapeutic Approach to Cardiovascular Diseases, Eds De Jong JW, Ferrari R,Kluwer Acad Publishers, The Netherlands 1995, Chapter 16
  159. Rizzon P et al, The Carnitine System: A Novel Therapeutic Approach to Cardiovascular Diseases, Eds De Jong JW, Ferrari R, Kluwer Acad Publishers, The Netherlands 1995, Chapter 17 160
  160. Costa M et al, Andrologia 26:155-159, 1994
  161. Vitali G et al, Drugs Exptl Clin Res 21:157-159, 1995
  162. Campaniello E et al, 4th Int Congress of Andrology, Firenze, 1989
  163. Loumbakis P et al, Eur Urol 30:255, 1996
  164. Marconi C et al, Eur J Appl Physiol 54:131-135, 1985
  165. Dragan GI et al, Rev Roum Morphol Embryol Physiol Physiologie 24:23-28, 1987
  166. Gorostiaga EM et al, Int J Sports Med 10:169-174, 1989
  167. Siliprandi N et al, Biochem Biophys Acta 1034:17-21, 1990
  168. Vecchiet L et al, Eur J Appl Physiol 61:486-490, 1990
  169. Paulson DJ et al, The Carnitine System: A Novel Therapeutic Approach to Cardiovascular Diseases, Eds. De Jong JW, Ferrari R, Kluwer Acad Publishers, The Netherlands 1995, Chapter 13
  170. Singh RB et al, Postgrad Med J 72:45-50, 1996
  171. Cherchi A et al, Intl J Clin Pharm Ther Tox 23:569-572, 1985
  172. Kamikawa T et al, Japan Heart J 25:587-597, 1984
  173. Cacciatore L et al, Drugs Exp Clin Res 17(4):255-235, 1991
  174. Jacoba KGC et al, Clin Drug Invest 11:90-96, 1996
  175. Luppa D et al, Carnitine – Pathobiochemical Basis and Clinical Applications, Eds. Seim H, Loster H, Ponte Press, Germany, 1996
  176. Cerretelli P et al, Intl J Sports Med 11:1-14, 1990
  177. Swart I et al, Nut Research 17:405, 1997
  178. Angelini C et al, Adv Clin Enzymol 4:103-110, 1986
  179. Giamberardino MA et al, Intl J Sports Med 17:320-324, 1996
  180. Bremer J, The Carnitine System: A Novel Therapeutic Approach to Cardiovascular Diseases, Eds. De Jong JW, Ferrari R, Kluwer Acad Publishers, The Netherlands 1995, Chapter 2
  181. Ramsey AC et al, Caries Research 9:13, 1975
  182. Onisi M, J Dental Health 5:138-139, 1985
  183. Cao J et al, Dental Health 31:86-89, 1987
  184. Ikuza S, Dentistry 67:770-778, 1980
  185. Paolino VJ et al, Am Assoc Dent Research 488 (abs), 1980
  186. Wu-Yuan CD et al, J Dent Research 67:51-55, 1988
  187. Itoh T, Nihon U J Oral Science 17:115-126,1991
  188. Otake S et al, Caries Research 25:438-443, 1991
  189. Sakanaka S et al, Agric Biol Chem 54:2925-2959, 1990
  190. Weiss EI, J Am Dent Assoc 129:1719-1723, 1998
  191. Vanfraecham HP, Folkers K, Biomed & Clin Aspects of Q10,Eds. Folkers K, Yamamura Y, Vol 3, Elsevier, Amsterdam 1981; pp235-241

Shop the Onnit x Marvel Hero Elite Series featuring epic tools for heroes in training.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Shares